@article{kraeberbodere:hal-02425339,
TITLE = {Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial},
AUTHOR = {Kraeber-Bodere, Francoise and Pallardy, Amandine and Maisonneuve, Herv{\'e} and Campion, Lo{\"i}c and Moreau, Anne and Soubeyran, Isabelle and Le Gouill, Steven and Tournilhac, Olivier and Daguindau, Etienne and Jardel, Henry and Morineau, Nadine and Bouabdallah, Krimo and Gyan, Emmanuel and Moles, Marie-Pierre and Gressin, Remy and Berthou, Christian and Sadot, Sophie and Moreau, Philippe and Deau, B{\'e}n{\'e}dicte and Bodet-Milin, Caroline and Cazeau, Anne-Laure and Garin, Etienne and Salaun, Pierre-Yves and Vuillez, Jean-Philippe and Gouilleux-Gruart, Val{\'e}rie and Barbet, Jacques and Wegener, William and Goldenberg, David M and Lamy, Thierry and Soubeyran, Pierre},
URL = {https://univ-tours.hal.science/hal-02425339},
JOURNAL = {The Lancet Haematology},
PUBLISHER = {Elsevier},
VOLUME = {4},
NUMBER = {1},
PAGES = {e35-e45},
YEAR = {2017},
MONTH = Jan, DOI = {10.1016/S2352-3026(16)30168-5},
HAL_ID = {hal-02425339},
HAL_VERSION = {v1},
}